Guillaume Médard

Guillaume Médard

Auto-generated profile, based on publicly available information

Guillaume Médard

Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Science
Verified
Journal Article
Open access
PDF file
SKSusan Klaeger
Susan Klaeger
SHStephanie Heinzlmeir
Stephanie Heinzlmeir
MWMathias Wilhelm
Mathias Wilhelm
HPHarald Polzer
Harald Polzer
BVBinje Vick
Binje Vick
BKBernhard Kuster
Bernhard Kuster
An atlas for drug interactions: Kinase inhibitors are an important class of drugs that block certain enzymes involved in diseases such as cancer and inflammatory disorders. There are hundreds of kinases within the human body, so knowing the kinase “target” of each drug is essential for developing successful treatment strategies. Sometimes clinical trials can fail because drugs bind more than one target. Yet sometimes off-target effects can be beneficial, and drugs can be repurposed for treatment of additional diseases. Klaegeret al.performed a comprehensive analysis of 243 kinase inhibitors that are either approved for use or in clinical trials. They provide an open-access resource of target summaries that could help researchers develop better drugs, understand how existing drugs work, and design more effective clinical trials.Science, this issue p.eaan4368

1 October 2016 in Immunity
Verified
Journal Article
Closed access
CGChristina J. Groß
Christina J. Groß
RMRitu Mishra
Ritu Mishra
KSKatharina S. Schneider
Katharina S. Schneider
GMGuillaume Médard
Guillaume Médard
JWJennifer Wettmarshausen
Jennifer Wettmarshausen
OGOlaf Groß
Olaf Groß

1 December 2017 in Cell Reports
Verified
Journal Article
Open access
KSKatharina S. Schneider
Katharina S. Schneider
CGChristina J. Groß
Christina J. Groß
RDRoland F. Dreier
Roland F. Dreier
BSBenedikt S. Saller
Benedikt S. Saller
RMRitu Mishra
Ritu Mishra
OGOlaf Groß
Olaf Groß
Inflammasomes activate the protease caspase-1, which cleaves interleukin-1β and interleukin-18 to generate the mature cytokines and controls their secretion and a form of inflammatory cell death called pyroptosis. By generating mice expressing enzymatically inactive caspase-1C284A, we provide genetic evidence that caspase-1 protease activity is required for canonical IL-1 secretion, pyroptosis, and inflammasome-mediated immunity. In caspase-1-deficient cells, caspase-8 can be activated at the inflammasome. Using mice either lacking the pyroptosis effector gasdermin D (GSDMD) or expressing caspase-1C284A, we found that GSDMD-dependent pyroptosis prevented caspase-8 activation at the inflammasome. In the absence of GSDMD-dependent pyroptosis, the inflammasome engaged a delayed, alternative form of lytic cell death that was accompanied by the release of large amounts of mature IL-1 and contributed to host protection. Features of this cell death modality distinguished it from apoptosis, suggesting it may represent a distinct form of pro-inflammatory regulated necrosis.

25 August 2013 in Nature Methods
Verified
Journal Article
Closed access
PDF file
HHHannes Hahne
Hannes Hahne
FPFiona Pachl
Fiona Pachl
BRBenjamin Ruprecht
Benjamin Ruprecht
SMStefan K Maier
Stefan K Maier
SKSusan Klaeger
Susan Klaeger
BKBernhard Kuster
Bernhard Kuster

28 September 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
LJLi Jiang
Li Jiang
BZBodong Zhang
Bodong Zhang
GMGuillaume Médard
Guillaume Médard
ASAri Paavo Seitsonen
Ari Paavo Seitsonen
FHFelix Haag
Felix Haag
APAnthoula C. Papageorgiou
Anthoula C. Papageorgiou
N-Heterocyclic carbenes wet the solid surfaces of group 11 metals with energetically favourable electron donating biscarbene metal complexes.

1 September 2018 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
DZDaniel Paul Zolg
Daniel Paul Zolg
MWMathias Wilhelm
Mathias Wilhelm
TSTobias Schmidt
Tobias Schmidt
GMGuillaume Médard
Guillaume Médard
JZJohannes Zerweck
Johannes Zerweck
BKBernhard Kuster
Bernhard Kuster
The analysis of the post-translational modification (PTM) state of proteins using mass spectrometry-based bottom-up proteomic workflows has evolved into a powerful tool for the study of cellular regulatory events that are not directly encoded at the genome level. Besides frequently detected modifications such as phosphorylation, acetylation and ubiquitination, many low abundant or less frequently detected PTMs are known or postulated to serve important regulatory functions. To more broadly understand the LC-MS/MS characteristics of PTMs, we synthesized and analyzed ~5,000 peptides representing 21 different naturally occurring modifications of lysine, arginine, proline and tyrosine side chains and their unmodified counterparts. The analysis identified changes in retention times, shifts of precursor charge states and differences in search engine scores between modifications. PTM-dependent changes in the fragmentation behavior were evaluated using eleven different fragmentation modes or collision energies. We also systematically investigated the formation of diagnostic ions or neutral losses for all PTMs, confirming 10 known and identifying 5 novel diagnostic ions for lysine modifications. To demonstrate the value of including diagnostic ions in database searching, we reprocessed a public data set of lysine crotonylation and showed that considering the diagnostic ions increases confidence in the identification of the modified peptides. To our knowledge, this constitutes the first broad and systematic analysis of the LC-MS/MS properties of common and rare PTMs using synthetic peptides, leading to direct applicable utility for bottom-up proteomic experiments.